期刊文献+

西藏地区睾丸和附睾疾病临床诊治分析 被引量:2

Diagnosis and treatment of testicular and epididymal diseases in Tibetan area
下载PDF
导出
摘要 目的:通过对我院睾丸和附睾疾病的临床资料进行分析,探讨西藏地区睾丸和附睾疾病临床常见类型及治疗、防治措施。方法:回顾性分析2007~2009年我科收治的105例睾丸、附睾病例。结果:我区睾丸、附睾疾病发病率仍以结核、肿瘤为主,105例患者中,睾丸或附睾结核27例,睾丸肿瘤21例,睾丸鞘膜积液20例,隐睾12例,睾丸或附睾炎性病变13例,睾丸脓肿7例,睾丸外伤5例。同时发现患病人群99%的为藏区农牧民。结论:藏区农牧民对此类疾病认知、预防及治疗意识低下,故作为医生及相关机构仍需加强对睾丸和附睾疾患的宣传。 Objective: To explore the clinical types,prevention and treatment of testicular and epididymal diseases in the Tibetan area.Methods: We retrospectively analyzed the clinical data of 105 cases of testicular or epididymal diseases treated in our department from 2007 to 2009.All the patients were permanent inhabitants in Tibet.Results: Among the 105 patients,the main types of testicular and epididymal diseases were tuberculosis(27 cases) and tumor(21 cases).And 99% of the patients were Tibetan farmers and herdsmen.Conclusion: Tibetan farmers and herdsmen have a poor knowledge about testicular and epididymal diseases and their prevention and treatment.Clinicians and related institutions need to strengthen health education on these diseases in Tibetan area to improve the early awareness,early diagnosis,early prevention and early treatment of testicular and epididymal diseases.
出处 《中华男科学杂志》 CAS CSCD 2012年第4期353-355,共3页 National Journal of Andrology
关键词 西藏 附睾结核 睾丸肿瘤 睾丸鞘膜积液 Tibetan area epididymal tuberculosis testis tumor testisticular hydrocele
  • 相关文献

参考文献13

二级参考文献32

共引文献2690

同被引文献25

  • 1蒋宇光,陈江华,姜睿,杭格日乐图,王广会,汪东,李福春,刘虎,石长江,吴红军,袁亚光.蒙古族睾丸肿瘤35例临床分析[J].中华男科学杂志,2006,12(5):397-400. 被引量:1
  • 2Albers P,Albrecht W,Algaba F,et al.EAU Guidelines on Testicular Cancer:2011 Update[J] .European Urology,2011:304-329.
  • 3Spermon JR,Hoffmann AL,Horenblas S,et al.European consensus on diagnosis and treatment of germ cell cancer:a report of the European germ cell cancer consensus group (EGCCCG)[J] .Ann Oncol 2004 ; 15:1377-1399.
  • 4Kondagunta GV,Motzer RJ,et al.Adjuvant chemotherapy for stage Ⅱ Nonseminomatous germ-cell tumors[J] .Urol Clin N Am,2007,34:199-185.
  • 5Christian Wintem,David Pfisterb,Jonas Busch,et al.Residual Tumor Size and IGCCCG Risk Classification Predict Additional Vascular Procedures in Patients with Germ Cell Tumors and Residual Tumor Resection:A Multicenter Analysis of the German Testicular Cancer Study Group[J] .European Urology,2012,61:403-409.
  • 6Nicola Nicolai,Rosalba Micelii,Andrea Necchi,et al.Retroperitoneal Lymph Node Dissection with No Adjuvant Chemotherapy in Clinical Stage Ⅰ Nonseminomatous Germ Cell Tumors:Long-Term Outcome and Analysis of Risk Factors of Recurrence[J] .European Urology,2010,58:912-918.
  • 7Stephen D,Beck W,Richard S,et al.Significance of Primary Tumor Size and Preorchiectomy Serum Tumor Marker Level in Predicting Pathologic Stage at Retroperitoneal Lymph Node Dissection in Clinical Stage A Nonseminomatous Germ Cell Tumors[J] .Urology,2007,69 (3):557-779.
  • 8Klein EA.Tumor markers in testis cancer[J] .Urol Clin North Am 1993; 20:67-73.
  • 9Williams SB,McDermott DW,Dock W,et al.Retroperitoneal lymph node dissection in patients with high risk testicular cancer[J] .J Oncol,2009,181(5):2097-2101.
  • 10Cherie H,Dunphy MD,Alberto G,et al.Clinical stage Ⅰ nonseminomatous and mixed germ cell tumors of the testis:A clinic pathologic study of 93 patients on a surveillance protocol after orchiectomy alone[J] .Cancer,1988,62:1203-1206.

引证文献2

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部